Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000032C9
CNY
35.62
-1.19 (-3.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
962.70
969.93
964.06
878.19
663.16
602.50
481.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
962.70
969.93
964.06
878.19
663.16
602.50
481.73
Raw Material Cost
392.98
420.59
415.85
378.49
261.02
194.05
149.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
76.98
78.03
76.18
67.38
53.71
47.97
37.36
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.63
6.23
14.06
3.70
3.01
0.11
0.07
Selling and Distribution Expenses
427.62
414.84
412.75
383.46
299.67
318.32
270.73
Other Expenses
-4.11
-6.40
-7.20
-5.71
-4.37
-3.50
-2.91
Total Expenditure (Excl Depreciation)
858.13
855.69
846.83
775.97
573.65
525.44
428.27
Operating Profit (PBDIT) excl Other Income
104.60000000000001
114.2
117.2
102.2
89.5
77.1
53.5
Other Income
31.94
22.16
16.36
10.59
10.77
7.42
21.92
Operating Profit (PBDIT)
171.52
166.70
150.88
128.60
112.03
96.09
87.22
Interest
1.63
6.23
14.06
3.70
3.01
0.11
0.07
Exceptional Items
0.01
0.00
0.00
0.00
0.00
0.77
0.00
Gross Profit (PBDT)
569.72
549.34
548.21
499.71
402.14
408.45
332.48
Depreciation
33.45
31.04
17.54
15.88
14.52
13.20
11.83
Profit Before Tax
136.45
129.43
119.29
109.03
94.50
83.55
75.32
Tax
17.03
17.70
16.03
14.47
13.40
11.77
10.64
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
120.27
110.43
101.16
93.17
79.12
71.78
64.68
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
120.27
110.43
101.16
93.17
79.12
71.78
64.68
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.35
1.11
1.98
1.39
1.98
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
119.92
111.55
103.15
94.56
81.09
71.78
64.68
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,635.22
1,549.05
929.65
791.38
720.78
674.71
611.60
Earnings per share (EPS)
1.15
1.13
1.17
1.09
0.92
0.83
0.75
Diluted Earnings per share
1.15
1.13
1.17
1.09
0.92
0.83
0.75
Operating Profit Margin (Excl OI)
11.02%
11.7%
12.13%
11.63%
13.08%
12.53%
11.1%
Gross Profit Margin
17.65%
16.54%
14.19%
14.22%
16.44%
16.06%
18.09%
PAT Margin
12.49%
11.39%
10.49%
10.61%
11.93%
11.91%
13.43%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -0.74% vs 0.60% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 7.53% vs 8.15% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -3.39% vs 7.43% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -74.19% vs -56.03% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
962.70
0
962.70
Other Operating Income
0.00
0.00
0.00
Total Operating income
962.70
0
962.70
Raw Material Cost
392.98
0
392.98
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
76.98
0
76.98
Power Cost
0
0
0.00
Manufacturing Expenses
1.63
0
1.63
Selling and Distribution Expenses
427.62
0
427.62
Other Expenses
-4.11
0.00
-4.11
Total Expenditure (Excl Depreciation)
858.13
0
858.13
Operating Profit (PBDIT) excl Other Income
104.56
0.00
104.56
Other Income
31.94
0
31.94
Operating Profit (PBDIT)
171.52
0
171.52
Interest
1.63
0
1.63
Exceptional Items
0.01
0
0.01
Gross Profit (PBDT)
569.72
0
569.72
Depreciation
33.45
0
33.45
Profit Before Tax
136.45
0
136.45
Tax
17.03
0
17.03
Provisions and contingencies
0
0
0.00
Profit After Tax
120.27
0
120.27
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
120.27
0
120.27
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.35
0
-0.35
Other related items
0.00
0.00
0.00
Consolidated Net Profit
119.92
0
119.92
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,635.22
0
1,635.22
Earnings per share (EPS)
1.15
0
1.15
Diluted Earnings per share
1.15
0
1.15
Operating Profit Margin (Excl OI)
11.02%
0%
0.00
11.02%
Gross Profit Margin
17.65%
0%
0.00
17.65%
PAT Margin
12.49%
0%
0.00
12.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 96.27 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -0.74% vs 0.60% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 11.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 7.53% vs 8.15% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.96 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -3.39% vs 7.43% in Dec 2023

Annual - Interest
Interest 0.16 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -74.19% vs -56.03% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.02%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023